BCYC — BICYCLE THERAPEUTICS PLC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About BICYCLE THERAPEUTICS PLC (BCYC)
BICYCLE THERAPEUTICS PLC (BCYC) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $2M. Across recent filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BCYC
How many top investors track BCYC
A small number of top investors own this.
BCYC Ownership Composition
How BICYCLE THERAPEUTICS PLC is held across tracked investor types, based on reported 13F positions.
- Other84.2%
- Hedge Funds15.8%
Tracked investors reporting BCYC
- Izzy EnglanderMar 31, 2026Millennium ManagementShares284KValue$1.3M% Portfolio0.00%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares410.7KValue$1.9M% Portfolio0.00%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares130.4KValue$605.2K% Portfolio0.00%
Recent activity
- $2.3MFeb 17, 2026
- $1.3MMay 15, 2026
- New$543.6KFeb 17, 2026
- New$1.9MMay 15, 2026
- New$605.2KMay 15, 2026
- New$1.5MNov 14, 2025
Frequently asked questions
- How many institutional investors hold BCYC?
- 3 tracked institutional investors disclosed a position in BCYC (BICYCLE THERAPEUTICS PLC) in their most recent 13F filing.
- Who is the largest institutional holder of BCYC?
- Izzy Englander, Millennium Management, holds the largest disclosed position in BCYC, valued at $2M.
- Did institutional ownership of BCYC increase or decrease?
- Across recent 13F filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 0 fully exited BCYC.
- Where does this BCYC ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.